Institution · Addiction Research Foundation
Most cited papers from Addiction Research Foundation
What are the most cited papers from Addiction Research Foundation?
The most cited paper from Addiction Research Foundation is "A method for estimating the probability of adverse drug reactions" (C. A. Naranjo, U. Busto, Edward M. Sellers et al., 1981), with 11,879 citations. Next come "Purification and properties" (1,717) and "Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor" (1,182).
Showing 50 of 60 papers. Every paper with more than 185 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | A method for estimating the probability of adverse drug reactions C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics | Aug 1981 | 11,879 |
| 2 | Purification and properties Brian M. Cox, K E Opheim, H. Teschemacher et al. · Life Sciences | Jun 1975 | 1,717 |
| 3 | Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor Charles Chavkin, Iain F. James, Avram Goldstein · Science | 22 Jan 1982 | 1,182 |
| 4 | Dynorphin-(1-13), an extraordinarily potent opioid peptide. Alan J. Goldstein, Shizuko Tachibana, Louise I. Lowney et al. · Proceedings of the National Academy of Sciences | Dec 1979 | 876 |
| 5 | The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine William A. Corrigall, Keith B.J. Franklin, Kathleen M. Coen et al. · Psychopharmacology | Jun 1992 | 834 |
| 6 | Reliability of a Timeline Method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations Linda Carter Sobell, Mark B. Sobell, Gloria I. Leo et al. · British Journal of Addiction | Apr 1988 | 796 |
| 7 | Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area William A. Corrigall, Kathleen M. Coen, Kathryn Adamson · Brain Research | Aug 1994 | 744 |
| 8 | The Prevalence of Psychiatric Disorders in Patients With Alcohol and Other Drug Problems Helen E. Ross · Archives of General Psychiatry | Nov 1988 | 732 |
| 9 | The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. H. Kalant · PubMed | 2 Oct 2001 | 619 |
| 10 | Thrills in response to music and other stimuli Avram Goldstein · Physiological Psychology | Mar 1980 | 533 |
| 11 | Opioid Peptides Endorphins in Pituitary and Brain Avram Goldstein · Science | 17 Sep 1976 | 517 |
| 12 | Drug reinforcement studied by the use of place conditioning in rat Ronald F. Mucha, Derek van der Kooy, Martha O'Shaughnessy et al. · Brain Research | Jul 1982 | 491 |
| 13 | Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain Carlo Colantuoni, J. Schwenker, Joseph McCarthy et al. · Neuroreport | Nov 2001 | 471 |
| 14 | A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes E.S. Messina, Rachel Fynvola Tyndale, Edward M. Sellers · Journal of Pharmacology and Experimental Therapeutics | Sep 1997 | 455 |
| 15 | The Generic Job Satisfaction Scale Scott A. MacDonald, Peter D. Maclntyre · Employee Assistance Quarterly | 30 May 1997 | 443 |
| 16 | Alcohol and Tension Reduction; A Review Howard Cappell, C. Peter Herman · Quarterly Journal of Studies on Alcohol | Mar 1972 | 437 |
| 17 | Recovery from alcohol problems with and without treatment: prevalence in two population surveys. Linda Carter Sobell, John Alastair Cunningham, Mark B. Sobell · American Journal of Public Health | Jul 1996 | 433 |
| 18 | The Family Assessment Measure Harvey A. Skinner, Paul D. Steinhauer, Jack Santa-Barbara · Canadian Journal of Community Mental Health | Sep 1983 | 430 |
| 19 | Specific receptor for the opioid peptide dynorphin: structure--activity relationships. Charles Chavkin, A Goldstein · Proceedings of the National Academy of Sciences | Oct 1981 | 426 |
| 20 | Dynorphin and Vasopressin: Common Localization in Magnocellular Neurons S.J. Watson, Huda Akil, Walter Fischli et al. · Science | 2 Apr 1982 | 417 |
| 21 | Reversible Cerebral Atrophy in Recently Abstinent Chronic Alcoholics Measured by Computed Tomography Scans Peter Louis Carlen, George Wortzman, Richard C. Holgate et al. · Science | 2 Jun 1978 | 401 |
| 22 | Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. A Goldstein, Walter Fischli, Louise I. Lowney et al. · Proceedings of the National Academy of Sciences | Nov 1981 | 399 |
| 23 | Normative Symbol Digit Modalities Test performance in a community-based sample Lorraine P. Sheridan, Hayley E. Fitzgerald, Kenneth M. Adams et al. · Archives of Clinical Neuropsychology | Sep 2005 | 367 |
| 24 | Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats A. D. Lê, Bui H. Quan, W. Juzytch et al. · Psychopharmacology | 14 Jan 1998 | 327 |
| 25 | Dynorphin immunocytochemistry in the rat central nervous system Henry Khachaturian, Stanley J. Watson, Michael Edward Lewis et al. · Peptides | Nov 1982 | 321 |
| 26 | Stereospecific Nicotine Receptors on Rat Brain Membranes Carmelo Romano, Avram Goldstein · Science | 7 Nov 1980 | 320 |
| 27 | Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Martin J. Jarvis, Michael A. Russell, Neal L. Benowitz et al. · American Journal of Public Health | Jun 1988 | 318 |
| 28 | Causes of Death of Alcoholics Wolfgang Schmidt, Jan de Lint · Quarterly Journal of Studies on Alcohol | Mar 1972 | 316 |
| 29 | CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats Yavin Shaham, Suzanne M. Erb, Shirley Leung et al. · Psychopharmacology | 5 May 1998 | 308 |
| 30 | The Metabolism of Ethanol and Its Metabolic Effects Rosemary D. Hawkins, H. Kalant · Pharmacological Reviews | Mar 1972 | 297 |
| 31 | Isolation H. Teschemacher, K E Opheim, Brian M. Cox et al. · Life Sciences | Jun 1975 | 285 |
| 32 | Comparison of the Distribution of Dynorphin Systems and Enkephalin Systems in Brain Stanley J. Watson, Henry Khachaturian, Huda Akil et al. · Science | 10 Dec 1982 | 281 |
| 33 | What Triggers the Resolution of Alcohol Problems Without Treatment?* Linda Carter Sobell, Mark B. Sobell, Tony Toneatto et al. · Alcoholism Clinical and Experimental Research | Apr 1993 | 275 |
| 34 | Nicotine self-administration in animals and humans: similarities and differences Jed E. Rose, William A. Corrigall · Psychopharmacology | 6 Mar 1997 | 264 |
| 35 | Inhibition by fluoxetine of cytochrome P450 2D6 activity S Victoria Otton, Dafang Wu, Russell T. Joffe et al. · Clinical Pharmacology & Therapeutics | Apr 1993 | 260 |
| 36 | Daily and Compulsive Internet Use and Well-Being in Adolescence: A Diathesis-Stress Model Based on Big Five Personality Traits Niels van der Aa, Geertjan J. Overbeek, Rutger C. M. E. Engels et al. · Journal of Youth and Adolescence | 31 Jul 2008 | 259 |
| 37 | Cannabis and mental illness: a review Darby J. E. Lowe, Julia Sasiadek, Alexandria S. Coles et al. · European Archives of Psychiatry and Clinical Neuroscience | 19 Dec 2018 | 256 |
| 38 | Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder Eli A. Stahl et al. · bioRxiv (Cold Spring Harbor Laboratory) | 7 Aug 2017 | 255 |
| 39 | Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. Michael A. Russell, R Merriman, J A Stapleton et al. · BMJ | 10 Dec 1983 | 250 |
| 40 | Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation Elizabeth M. Oliva, Thomas R. Bowe, Ajay Manhapra et al. · BMJ | 4 Mar 2020 | 241 |
| 41 | The serotonin uptake inhibitor citalopram attenuates ethanol intake Claudio A. Naranjo, Edward M. Sellers, John T. Sullivan et al. · Clinical Pharmacology & Therapeutics | Mar 1987 | 240 |
| 42 | Diazepam loading: Simplified treatment of alcohol withdrawal Edward M. Sellers, C. A. Naranjo, M Harrison et al. · Clinical Pharmacology & Therapeutics | Dec 1983 | 233 |
| 43 | Development of Optimal Treatment Tactics for Alcohol Withdrawal. I. Assessment and Effectiveness of Supportive Care Joanne Margaret Shaw, Gregory S. Kolesar, Edward M. Sellers et al. · Journal of Clinical Psychopharmacology | Nov 1981 | 233 |
| 44 | Partial antagonism of placebo analgesia by naloxone Priscilla Grevert, Leonard H. Albert, Avram Goldstein · Pain | Jun 1983 | 231 |
| 45 | Venlafaxine oxidationin vitrois catalysed by CYP2D6 S Victoria Otton, Simon E. Ball, Siu Wah Cheung et al. · British Journal of Clinical Pharmacology | Feb 1996 | 229 |
| 46 | Internet Sex Addiction KIMBERLY S. YOUNG · American Behavioral Scientist | 26 Jul 2008 | 228 |
| 47 | Alcohol and Crimes of Violence Kai Pernanen | 1976 | 226 |
| 48 | Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers Claudio A. Naranjo, Edward M. Sellers, Carol Roach et al. · Clinical Pharmacology & Therapeutics | Mar 1984 | 225 |
| 49 | The reliability of alcohol abusers' self-reports of drinking and life events that occurred in the distant past. Linda Carter Sobell, Mark B. Sobell, Diane Riley et al. · Journal of Studies on Alcohol | May 1988 | 220 |
| 50 | Immunoreactive dynorphin in pituitary and brain. A Goldstein, Vartan E. Ghazarossian · Proceedings of the National Academy of Sciences | Oct 1980 | 220 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.